5.78
price up icon0.87%   0.05
pre-market  시장 영업 전:  5.77   -0.01   -0.17%
loading

4 D Molecular Therapeutics Inc 주식(FDMT)의 최신 뉴스

pulisher
04:15 AM

Will earnings trigger a reversal in 4D Molecular Therapeutics Inc.Volume Spike Detection for Early Breakouts - Newser

04:15 AM
pulisher
04:13 AM

Heatmap analysis for 4D Molecular Therapeutics Inc. and competitors7-Day Equity Return Range Forecast Model - Newser

04:13 AM
pulisher
02:19 AM

Can you recover from losses in 4D Molecular Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser

02:19 AM
pulisher
Aug 07, 2025

What makes 4D Molecular Therapeutics Inc. stock attractive to long term investorsFree Real Market Momentum Signal Generator - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Published on: 2025-08-07 03:01:11 - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

4D Molecular Therapeutics (FDMT) to Release Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

4D Molecular Therapeutics shares fall 2.73% intraday after announcing participation in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Volatility clustering patterns for 4D Molecular Therapeutics Inc.Short-Term Sector Movement Forecast Generator - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Using fundamentals and technicals on 4D Molecular Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Developing predictive dashboards with 4D Molecular Therapeutics Inc. dataEquity Portfolio Outlook and Performance Summary - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

4D Molecular Therapeutics Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

How to build a custom watchlist for 4D Molecular Therapeutics Inc.Entry Opportunity Screener with Confirmation - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Fibonacci Support Holding Strong in 4D Molecular Therapeutics Inc.Conservative Long Term Growth Plans Under Review - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Why is 4D Molecular Therapeutics Inc. stock attracting strong analyst attentionAchieve consistent profits with proven methods - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

4D Molecular Therapeutics’ (FDMT) Buy Rating Reiterated at Chardan Capital - Defense World

Aug 04, 2025
pulisher
Aug 03, 2025

Is 4D Molecular Therapeutics Inc. a growth stock or a value stockProven strategies for superior portfolio growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of 4D Molecular Therapeutics Inc. stockGet daily expert analysis on top stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is 4D Molecular Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Capital Preserving Trade Plan Templates - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in 4D Molecular Therapeutics Inc. stockExplosive capital gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are 4D Molecular Therapeutics Inc. company’s key revenue driversCapitalize on fast-growing investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Does 4D Molecular Therapeutics Inc. stock perform well during market downturnsRapid profit acceleration - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is 4D Molecular Therapeutics Inc. stock overvalued or undervaluedInvest smarter with data-backed trading alerts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about 4D Molecular Therapeutics Inc.Spectacular growth rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is 4D Molecular Therapeutics Inc. stock expected to show significant growthMassive stock growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attentionFree Low Risk Swing Trade Opportunity List - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Inc. stock prediction for this weekLow Drawdown Picks with Weekly Updates - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Showcases Positive Trial Results, Charts New Growth Trajectory - timothysykes.com

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular (FDMT) Stock Climbs Following Promising Retina Therapy Data - Stocks Telegraph

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study - 富途牛牛

Aug 01, 2025
pulisher
Aug 01, 2025

How volatile is 4D Molecular Therapeutics Inc. stock compared to the marketEntry Signal Forecasts With Low Risk - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular: Time to Buy After Recent Surge? - StocksToTrade

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics: A Market Shift? - timothysykes.com

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics shares rise 30.44% premarket after presenting positive 60-week results for 4D-150. - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Chardan Capital Maintains Buy on 4D Molecular, Raises PT to $25 - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics stock soars after positive DME trial results By Investing.com - Investing.com Canada

Aug 01, 2025
pulisher
Aug 01, 2025

Will a bounce in 4D Molecular Therapeutics Inc. offer an exitPrice Action Trading with Volume Confirmation - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics Shares Surge 50.89% on Positive Clinical Trial Results - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics (FDMT) Shares Soar 37.78% on Positive Clinical Trial Results - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

4D Molecular Therapeutics shares rise 56% premarket after presenting positive 60-week results for 4D-150. - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

4D Molecular (FDMT) Shows Promising Results in Clinical Trial fo - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

How does 4D Molecular Therapeutics Inc. compare to its industry peersBeginner Investor Strategy With Proven Results - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Trend Reversal Possible in 4D Molecular Therapeutics Inc. Charts IndicateEarnings Play Trade Plan With Alerts Shared - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Advanced analytics toolkit walkthrough for 4D Molecular Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Weiss Ratings Reiterates Sell (D-) Rating for 4D Molecular Therapeutics (NASDAQ:FDMT) - Defense World

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 16:44:26 - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How 4D Molecular Therapeutics Inc. stock performs during market volatilityPortfolio Positioning Strategy With Timing - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What makes 4D Molecular Therapeutics Inc. stock price move sharplyMinimal Risk Growth Investment Opportunity Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

4D Molecular Therapeutics Bets Big On Gene Therapy Breakthroughs - Finimize

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:03:48 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 02:38:48 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Trapped Investors in 4D Molecular Therapeutics Inc. Await Breakout SignalTriple Digit Return Stock Predictions Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive 4D Molecular Therapeutics Inc. stock higher in 2025Stay informed with expert market forecasts - Jammu Links News

Jul 28, 2025
$78.20
price up icon 0.71%
$37.01
price down icon 0.30%
$109.30
price down icon 1.76%
$28.07
price down icon 1.58%
$111.35
price up icon 0.04%
biotechnology ONC
$298.29
price down icon 0.08%
자본화:     |  볼륨(24시간):